Journalist Alex Berenson joined "The John Curley Show" to discuss his settlement and what he sees as a pattern of fear-based ...

The agreement covers eight early-stage trials from Innovent and four discovery programmes from global giant Pfizer China's Innovent Biologics has signed a global collaboration with pharmaceutical ...

After decades of sustained investment in antibiotic research, Wockhardt has secured approvals for its breakthrough drug ...

The Dividend Harvesting Portfolio reached a record $39,166.48, up 43.47% on invested capital. Read the full analysis here.

Bay Area Lyme Foundation, the nation's leading public charity funder of Lyme disease research, raised $900,000 at LymeAid ...

Innovent Biologics rose as much as 10%, after entering a strategic global licensing and collaboration agreement with Pfizer ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

As Summit Therapeutics’ Chinese partner prepares to reveal data for a key trial at ASCO, analysts consider the impact on rivals Merck, Bristol Myers Squibb and BioNTech.

Eli Lilly, with a busier-than-ever business development team, has made a major vaccine play‚ months after hiring veteran vaccine regulator Peter Marks following his FDA departure. Eli Lilly is ...

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity ...